Skip to main content
HUALAN GROUP CO.,LTD. logo

HUALAN GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 301027 ISIN · CNE100004MH7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2023-11-17 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 301027

About HUALAN GROUP CO.,LTD.

https://www.gxhl.com

Hualan Group Co., Ltd. specializes in the research, development, and manufacturing of primary pharmaceutical packaging materials. The company's core product portfolio includes high-quality butyl rubber stoppers, aluminum-plastic combination caps, and plastic components designed for injectable medications and infusion sets. These products are engineered to ensure drug stability and compatibility, meeting international quality standards such as GMP. Serving a global clientele of pharmaceutical manufacturers, the group focuses on advanced material science and precision manufacturing to provide secure sealing solutions for vaccines, antibiotics, and blood products. By integrating R&D with large-scale production capabilities, the company maintains a significant role in the pharmaceutical supply chain, emphasizing safety and reliability in drug delivery systems.

Recent filings

Filing Released Lang Actions
关于更换保荐代表人的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change of the company's sponsor representative (保荐代表人) related to the company's IPO and ongoing supervision. It includes details about the replacement of the sponsor representative and a brief resume of the new representative. There is no financial data, no report attached or referenced as being published, and no mention of voting results or management changes at the board level. This is a regulatory announcement about a procedural change related to the IPO sponsor representative. It does not fit into categories like Annual Report, Interim Report, or Management Reports. It is best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-11-17 Chinese
关于全资子公司取得建筑工程施工总承包一级资质的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Huazhong Group regarding its wholly-owned subsidiary obtaining a first-class qualification for general contracting of construction projects. It includes details about the qualification certificate, its impact on the company, and a statement of authenticity by the board. The document is short (646 characters) and does not contain financial data, financial results, or detailed reports. It is an announcement of a corporate event related to qualifications and business capabilities, not a financial report, management change, or regulatory filing. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other specific categories.
2023-11-15 Chinese
第四届董事会第十九次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a board meeting resolution announcement from Huazhou Group, specifically the 19th meeting of the 4th board. It includes the approval of the company's 2023 third quarter report but does not contain the report itself. It states that the full 2023 third quarter report is available on an external website (cninfo.com.cn). The document is short (758 characters) and serves as an announcement of the board meeting decisions and the approval of the quarterly report, not the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and board meeting resolution notice, rather than an Interim/Quarterly Report (IR) or Annual Report (10-K).
2023-10-24 Chinese
2023年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "华蓝集团股份公司2023 年第三季度报告" which translates to "Hualan Group Co., Ltd. 2023 Third Quarter Report." It contains detailed financial data including income statement, balance sheet, cash flow statement, and notes for the third quarter of 2023. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the period ending September 30, 2023. It also mentions that the report is unaudited. The length of the document (11,960 characters) and the detailed financial content confirm it is a full interim/quarterly financial report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-10-24 Chinese
关于2023年第三季度计提减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 华蓝集团股份公司 regarding the impairment provisions made in the third quarter of 2023. It details the amounts of impairment provisions for accounts receivable, other receivables, and contract assets, the methods used for impairment testing, and the impact on the company's profit. The document is relatively short (2683 characters) and focuses on a specific accounting adjustment rather than providing a full financial report or comprehensive quarterly financial statements. It does not contain full financial statements or detailed financial analysis typical of an Interim/Quarterly Report (IR). Instead, it is a regulatory announcement about impairment provisions, which fits best under Regulatory Filings (RNS) as it does not meet the criteria for a full financial report or other specific categories.
2023-10-24 Chinese
第四届监事会第十五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board of 华蓝集团股份公司 regarding the approval of the company's 2023 third quarter report. It states that the third quarter report was reviewed and found compliant, but the full report is disclosed elsewhere (on a website). The document itself does not contain the actual financial data or the full report, only the resolution and voting results. The document length is short (757 characters) and it serves as an announcement of the meeting decision and the approval of the quarterly report, not the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and meeting resolution notice, not an Interim/Quarterly Report (IR) or Annual Report (10-K).
2023-10-24 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.